Pfizer sees robust COVID-19 vaccine demand for years, US$26 billion in 2021 sales

Pfizer says it told India there no safety concern with its COVID-19 vaccine

Pfizer on Tuesday (May 4) raised its forecast for 2021 COVID-19 vaccine sales by more than 70 per cent to US$26 billion and said demand from governments around the world fighting to halt the pandemic could contribute to its growth for years to come.

Continue reading at